List of contributors

Hikmat Al-Ahmadie MD
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Andrea B. Apolo MD
Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA

Jessie L.S. Au PharmD, PhD
Chief Scientific Officer, Optimum Therapeutics, LLC, San Diego, CA, USA; Henry D & Ida Mosier Chair of Pharmaceutical Sciences, University of Oklahoma, Oklahoma City, OK, USA; Adjunct Professor of Surgery, Medical University of South Carolina, Charleston, SC, USA; Adjunct Professor of Medicine, Taipei Medical University, Taiwan; Distinguished University Professor Emeritus, The Ohio State University, Columbus, OH, USA

Dean F. Bajorin MD
Weill Cornell Medical College, New York, NY, USA

Rick Bangs MD, MS
BCAN, SWOG, and NCI Patient Advocate, Rochester Hills, MI, USA

Joaquim Bellmunt MD
Bladder Cancer Center, Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA, USA; University Hospital del Mar-IMIM, Barcelona, Spain

Laura A. Bertrand MD
Department of Urology, University of Iowa, Iowa City, IA, USA

Bernard H. Bochner MD
Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Lior Z. Braunstein MD
Harvard Radiation Oncology Program, Boston, MA, USA

Fabio Calabró MD
Department of Medical Oncology, San Camillo Forlanini Hospitals, Rome, Italy

Eugene K. Cha
Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Kevin Chan MD
Division of Urology and Urologic Oncology, City of Hope National Medical Center, Duarte, CA, USA

G. John Chen
Division of Health Services Research, University of Kansas School of Medicine, Kansas City, KS, USA

Guido Dalbagni MD
Attending Surgeon, Department of Urology, Memorial Sloan-Kettering Cancer Center, and Professor of Urology, Weill Cornell Medical College, New York, NY, USA

Siamak Daneshmand MD
USC Institute of Urology, USC/Norris Comprehensive Cancer Center, Los Angeles, CA, USA

Maria De Santis MD
Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna) and Applied Cancer Research - Institution for Translational Oncology Vienna (ACR-ITR VIEnna) - KFJ Hospital, Vienna, Austria

Scott Delacroix, Jr MD
Assistant Professor, Department of Urology, Louisiana State University School of Medicine, New Orleans, LA, USA

Colin P.N. Dinney MD
Professor, Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Jason A. Efstathiou MD
Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA

André P. Fay MD
Bladder Cancer Center, Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA, USA

Margit Fisch MD
Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Thomas W. Flaig MD
Department of Medicine, Division of Medical Oncology, University of Colorado Denver, and University of Colorado Cancer Center, Aurora, CO, USA

Georgios Gakis
Department of Urology, University Hospital Tübingen, Tübingen, Germany

Matthew D. Galsky MD
Associate Professor of Medicine; Director of Genitourinary Medical Oncology, Icahn School of Medicine at Mount Sinai, and The Tisch Cancer Institute, New York, NY, USA

Nilay M. Gandhi MD
James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA

J.M. Gaya MD
Department of Urological Oncology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain

Scott M. Gilbert MD MS
Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Heather Honoré Goltz
College of Public Service, University of Houston-Downtown, and Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX, USA

John L. Gore
Department of Urology, University of Washington, Seattle, WA, USA

Ahmed Haddad MD
Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX, USA

Noah M. Hahn MD
Associate Professor of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA

Donna E. Hansel MD, PhD
Professor, Department of Pathology; Chief, Division of Anatomic Pathology, University of California, San Diego, La Jolla, CA, USA

Harry W. Herr MD
Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Gopa Iyer MD
Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Nicholas D. James MBBS, PhD
School of Cancer Sciences, University of Birmingham, Birmingham, UK

George J.S. Kallingal MD, MPH
Clinical Instructor, Department of Urology, University of Miami, Miami, FL, USA

Ashish M. Kamat MD
Associate Professor, Department of Urology, MD Anderson Cancer Center, Houston, TX, USA

Mark Kawachi MD
Division of Urology and Urologic Oncology, City of Hope National Medical Center, Duarte, CA, USA

Jaegil Kim MD
Broad Institute of Harvard and MIT, Cambridge, MA, USA

William Y. Kim MD
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Tobias Klatte
Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

Badrinath Konety
Department of Urology, University of Minnesota, Minneapolis, MN, USA

Theresa Koppie
Department of Urology, University Hospital Tübingen, Tübingen, Germany

Marc A. Kowalkowski
Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA

David J. Kwiatkowski MD
Broad Institute of Harvard and MIT, Cambridge, MA, USA and Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Donald L. Lamm MD
Clinical Professor, University of Arizona; Director, BCG Oncology, Phoenix, AZ, USA

David M. Latini PhD
Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA

Nathan Lawrentschuk MD
University of Melbourne, Department of Surgery; Olivia Newton-John Cancer Research Institute, Austin Hospital and Peter MacCallum Cancer Centre, Division of Cancer Surgery, Melbourne, Australia

Cheryl T. Lee MD
Department of Urology, University of Michigan, Ann Arbor, MI, USA

Seth P. Lerner MD, FACS
Department of Urology, Baylor College of Medicine, Houston, TX, USA

Jeffrey J. Leow MD
Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Urology, Tan Tock Seng Hospital, Singapore

Joseph C. Liao
Department of Urology, Stanford University School of Medicine, Stanford, CA, USA

Fredrik Liedberg MD
Department of Urology, Lund University, Malmö, Sweden

Jen-Jane Liu
Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA

Yair Lotan MD
Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX, USA

David J. McConkey MD
Departments of Urology and Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Edward M. Messing MD, FACS
W.W. Scott Professor and Chairman, Department of Urology, University of Rochester, School of Medicine and Dentistry, Rochester, New York, USA

Matthew I. Milowsky MD
Department of Medicine, Division of Hematology/Oncology, University of North Carolina at Chapel Hill, and Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA

Nihal E. Mohamed
Department of Urology and Oncological Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Andreas Neisius MD
Department of Urology, University Medical Center, Johannes Gutenberg University, Mainz, Germany

Matthew Nielsen MD, MS
Assistant Professor, Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Michael A. O'Donnell MD
Professor and Director of Urologic Oncology, Department of Urology, University of Iowa, Iowa City, IA, USA

Peter H....